Status:
COMPLETED
Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination
Lead Sponsor:
Larissa University Hospital
Conditions:
Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to examine the ocular hypotensive effect of Bimatoprost and the potential additional effect of the Bimatoprost/Timolol fixed combination in eyes with ocular hypertension, ...
Eligibility Criteria
Inclusion
- Primary open angle glaucoma
- Exfoliation glaucoma
- Ocular hypertension
Exclusion
- Younger than 18 years old
- Inability to understand and/or follow study requirements
- Women of childbearing potential not using reliable birth control, pregnant or lactating women
- History of chronic obstructive pulmonary disease, heart failure, 2nd or 3rd AV block
- Anticipated modification of treatment for systemic hypertension during the study period
- History of ocular herpes, corneal scarring, conventional or laser surgery or macular pathology
- History of allergy, poor tolerability or poor response to study medication
- Best corrected visual acuity less than 0.4
- Significant visual field defect (MD\<15.0 dB)
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00941096
Start Date
July 1 2009
End Date
November 1 2010
Last Update
November 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Eye Clinic
Larissa, Thessaly, Greece, 41110